Coadministered pneumococcal conjugate vaccine decreases immune response to hepatitis A vaccine: a randomized controlled trial.

Last updated on 16-1-2024 by Inge Roukaerts

Public Access


Peer reviewed scientific article



OBJECTIVES: We explored the influence of coadministration on safety and immunogenicity of the most common travellers’ vaccine hepatitis A (HepA) and the pneumococcal conjugate vaccine (PCV) increasingly used both at home and before travel. METHODS: Volunteers aged ≥18 years (n = 305) were randomly assigned 1:1:1 into three groups receiving: 13-valent PCV (PCV13) + HepA, PCV13, or HepA. Anti-pneumococcal IgG concentrations, opsonophagocytic activity (OPA) titres, and total hepatitis A antibody (anti-HAV) concentrations were measured before and 28 ± 3&nbs…

Associated health topics:

QR code

QR code for this page URL